Stay updated on 89Zr-Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the 89Zr-Pembrolizumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, indicating a new version of the page. This update appears to be a maintenance/version update rather than a modification to study data or public content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision tag was updated to v3.5.4, indicating a small documentation or backend update. The visible study information and layout remain unchanged.SummaryDifference0.1%

- Check47 days agoChange DetectedThe ClinicalTrials.gov page revision label updates from **v3.5.2** to **v3.5.3**, indicating a site/version release with no change to the study’s informational content.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a new version label 'Revision: v3.5.0' and removed 'Revision: v3.4.3' from the site metadata.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor site version update with no visible changes to core content or functionality.SummaryDifference0.1%

Stay in the know with updates to 89Zr-Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.